FRANK A. KAPRAL, Ph.D.
Staphylococcus aureus strains recovered from patients with toxic shock syndrome were examined for their ability to produce epidermal toxin. Seventy-three percent of 52 strains elaborated the toxin whereas only 18% of 106 control strains did so. There was no significant difference in the hemolysin patterns shown by the two groups of organisms.
KAPRAL FA. Epidermal Toxin Production by Staphylococcus aureus Strains from Patients with Toxic Shock Syndrome. Ann Intern Med. ;96:972–974. doi: 10.7326/0003-4819-96-6-972
Download citation file:
Published: Ann Intern Med. 1982;96(6_Part_2):972-974.
Infectious Disease, Multi-Organ Failure and Sepsis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use